We can buy a wide range of ASX shares. Some get little investor attention, while others are rated buys by many analysts.
When numerous investment professionals think a stock is a buy, it could suggest there's a clear opportunity.
Let's look at two of the ASX shares with the biggest number of buy ratings right now.
Image source: Getty Images
ALS Ltd (ASX: ALQ)
ALS describes itself as a global leader in testing. It says it provides comprehensive testing solutions to clients in a wide range of industries around the world. Its two main segments are commodities and life sciences.
FY26 was a strong year for the ASX share, with 10.7% growth of revenue, 19.3% growth of underlying operating profit (EBIT) and 25.8% growth of underlying net profit after tax (NPAT).
The company has started FY27 well, stating that it's on track to deliver high-single-digit organic revenue growth and margin improvement consistent with FY26.
The commodities business' organic revenue growth is trending above the 15% to 17% guided range for the first half, with continuation of the positive exploration conditions and activity levels from the junior miners continuing to grow and outpace major and mid-tier miners.
ALS' life sciences division's organic revenue growth has improved from the second half of FY26, but it's still below mid-single-digit expectations.
According to CMC Invest, analysts have made six rating calls on the business in the last three months. Five of them were buy ratings, and one was a hold.
Cuscal Ltd (ASX: CCL)
Cuscal is the other ASX share I want to highlight. It's an authorised deposit-taking institution (ADI) with the licences, connectivity and processing capability to support all payment types and regulated data services. It was only listed on the ASX in November 2024.
The company says that the combination of these capabilities and credentials within a single organisation in Australia is limited to the four major ASX bank shares and Cuscal.
Cuscal had a solid FY26 – statutory NPAT rose by 49% to $42.7 million. Underlying net profit rose 20% to $46.2 million, and underlying net operating income grew 20% to $347.7 million.
It acquired Indue on 1 December 2025 and Paymark on 29 May 2026, adding around $40 million to its net operating income. Those acquisitions increased its scale, strengthened its position across Australia and New Zealand, and expanded its range of payment capabilities it provides to clients.
The ASX share expects to deliver "strong profit growth" in FY27, supported by resilient transaction volumes, the acquisitions and cost management. It expects FY27 to show growth in the mid-20 % range for both transaction volumes and underlying net profit.
According to CMC Invest, there have been five analyst ratings on the business in the last three months, with four of those being a buy and one being a hold.
